Main Content
Main Menu
Search
Menu
People
Practices
Firm
Firm
About Us
Leadership
Pro Bono & Community Involvement
Contact Us
Contact Us
Directions
Insights
Insights
Media Mentions
Press Releases
Alerts
Articles
Blogs
Blog Posts
Newsletters
Podcasts
Events
Handbooks
Subscribe
Contact Us
Careers
Careers
Attorneys
Lateral Openings
Law Students
Professional Staff
Message from the Managing Partner
Better Every Day
Diversity
Diversity
Affinity Groups
Pipeline Initiatives
Signal Group
Trade Analytics Group
Trade Analytics Group
Wiley Trade Analytics Group (TAG)
Case Studies / Success
Team
Resource Centers
Resource Centers
Biden Administration Resource Center
COVID-19 Resource Center
Subscribe
Article
February 15, 2018
The Vexing Problem of Defining Intended Use: A Proposed Solution
Bloomberg Law’s Medical Devices Law & Industry Report
February 15, 2018
Related Materials
The-Vexing-Problem-of-Defining-Intended-Use-A-Proposed-Solution.pdf
Authors
Bert W. Rein
Founder
202.719.7080
brein@wiley.law
Practice Areas
FDA Regulatory Compliance
Food & Drug
By using this site, you agree to our updated
Privacy Policy
,
Terms & Conditions
, and
Cookies Policy
.
